載入...
Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria
Peroxisome proliferator-activated receptors (PPARs) alter the expression of genes involved in regulating lipid metabolism. Rosiglitazone, a PPARγ agonist, induces tissue-specific effects on lipid metabolism; however, its mode of action in skeletal muscle remains unclear. Since fatty acid translocase...
Na minha lista:
Main Authors: | , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Blackwell Science Inc
2008
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2375706/ https://ncbi.nlm.nih.gov/pubmed/18238811 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1113/jphysiol.2007.146563 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|